Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 277

1.

Long-term incobotulinumtoxinA treatment for chronic sialorrhea: Efficacy and safety over 64 weeks.

Jost WH, Friedman A, Michel O, Oehlwein C, Slawek J, Bogucki A, Ochudlo S, Banach M, Pagan F, Flatau-Baqué B, Dorsch U, Csikós J, Blitzer A.

Parkinsonism Relat Disord. 2019 Nov 26;70:23-30. doi: 10.1016/j.parkreldis.2019.11.024. [Epub ahead of print]

PMID:
31794936
2.

Long-Term Efficacy of Safinamide on Symptoms Severity and Quality of Life in Fluctuating Parkinson's Disease Patients.

Cattaneo C, Jost WH, Bonizzoni E.

J Parkinsons Dis. 2019 Sep 25. doi: 10.3233/JPD-191765. [Epub ahead of print]

PMID:
31594253
3.

Therapy of Sialorrhea with Botulinum Neurotoxin.

Jost WH, Bäumer T, Laskawi R, Slawek J, Spittau B, Steffen A, Winterholler M, Bavikatte G.

Neurol Ther. 2019 Dec;8(2):273-288. doi: 10.1007/s40120-019-00155-6. Epub 2019 Sep 21. Review.

PMID:
31542879
4.

Torticaput versus Torticollis: Clinical Effects with Modified Classification and Muscle Selection.

Jost WH.

Tremor Other Hyperkinet Mov (N Y). 2019 Jul 12;9. doi: 10.7916/tohm.v0.647. eCollection 2019.

5.

[Therapy of sialorrhea with botulinum toxin].

Jost WH, Bäumer T, Laskawi R, Spittau B, Steffen A, Winterholler M.

Fortschr Neurol Psychiatr. 2019 Oct;87(10):554-563. doi: 10.1055/a-0958-2417. Epub 2019 Jul 25. German.

PMID:
31344747
6.

Imaging cardiac sympathetic innervation with MIBG: linear conversion of the heart-to-mediastinum ratio between different collimators.

Brumberg J, Blazhenets G, Schröter N, Frings L, Jost WH, Lapa C, Meyer PT.

EJNMMI Phys. 2019 Jul 23;6(1):12. doi: 10.1186/s40658-019-0250-2.

7.

The challenge of pain in the pharmacological management of Parkinson's disease.

Jost WH, Buhmann C.

Expert Opin Pharmacother. 2019 Oct;20(15):1847-1854. doi: 10.1080/14656566.2019.1639672. Epub 2019 Jul 10. Review.

PMID:
31290336
8.

α-Synuclein in Parkinson's disease: causal or bystander?

Riederer P, Berg D, Casadei N, Cheng F, Classen J, Dresel C, Jost W, Krüger R, Müller T, Reichmann H, Rieß O, Storch A, Strobel S, van Eimeren T, Völker HU, Winkler J, Winklhofer KF, Wüllner U, Zunke F, Monoranu CM.

J Neural Transm (Vienna). 2019 Jul;126(7):815-840. doi: 10.1007/s00702-019-02025-9. Epub 2019 Jun 25. Review.

PMID:
31240402
9.

Dynamics of device-based treatments for Parkinson's disease in Germany from 2010 to 2017: application of continuous subcutaneous apomorphine, levodopa-carbidopa intestinal gel, and deep brain stimulation.

Richter D, Bartig D, Jost W, Jörges C, Stumpe B, Gold R, Krogias C, Tönges L.

J Neural Transm (Vienna). 2019 Jul;126(7):879-888. doi: 10.1007/s00702-019-02034-8. Epub 2019 Jun 20.

PMID:
31222604
10.

[Hypersalivation - Update of the S2k guideline (AWMF) in short form].

Steffen A, Jost W, Bäumer T, Beutner D, Degenkolb-Weyers S, Groß M, Grosheva M, Hakim S, Kahl KG, Laskawi R, Lencer R, Löhler J, Meyners T, Rohrbach-Volland S, Schönweiler R, Schröder SC, Schröder S, Schröter-Morasch H, Schuster M, Steinlechner S, Urban R, Guntinas-Lichius O.

Laryngorhinootologie. 2019 Jun;98(6):388-397. doi: 10.1055/a-0874-2406. Epub 2019 Jun 5. German.

PMID:
31167292
11.

Dyskinesia in multiple system atrophy and progressive supranuclear palsy.

Jost WH, Lingor P, Tönges L, Schwarz J, Buhmann C, Kassubek J, Schrag A.

J Neural Transm (Vienna). 2019 Jul;126(7):925-932. doi: 10.1007/s00702-019-02012-0. Epub 2019 May 13. Review.

PMID:
31087195
12.

[S1-Guideline for Diagnosis and Treatment of Erectile Dysfunction].

Haensch CA, Hilz M, Jost W, Kaufmann A, Kessler T, Lahrmann H.

Fortschr Neurol Psychiatr. 2019 Apr;87(4):225-233. doi: 10.1055/a-0747-5892. Epub 2019 Apr 18. Review. German.

PMID:
30999379
13.

Hypersalivation: update of the German S2k guideline (AWMF) in short form.

Steffen A, Jost W, Bäumer T, Beutner D, Degenkolb-Weyers S, Groß M, Grosheva M, Hakim S, Kahl KG, Laskawi R, Lencer R, Löhler J, Meyners T, Rohrbach-Volland S, Schönweiler R, Schröder SC, Schröder S, Schröter-Morasch H, Schuster M, Steinlechner S, Urban R, Guntinas-Lichius O.

J Neural Transm (Vienna). 2019 Jul;126(7):853-862. doi: 10.1007/s00702-019-02000-4. Epub 2019 Apr 10. Review.

PMID:
30972507
14.

[Therapy of Hemifacial Spasm with Botulinum Toxin].

Jost WH, Laskawi R, Palmowski-Wolfe A, Urban PP.

Laryngorhinootologie. 2019 Apr;98(4):247-251. doi: 10.1055/a-0834-4188. Epub 2019 Apr 9. German.

PMID:
30968378
15.

Time for a new definition of Parkinson's disease.

Jost WH, Reichmann H.

J Neural Transm (Vienna). 2019 Jul;126(7):801. doi: 10.1007/s00702-019-01999-w. Epub 2019 Apr 5. No abstract available.

PMID:
30953163
16.

SIAXI: Placebo-controlled, randomized, double-blind study of incobotulinumtoxinA for sialorrhea.

Jost WH, Friedman A, Michel O, Oehlwein C, Slawek J, Bogucki A, Ochudlo S, Banach M, Pagan F, Flatau-Baqué B, Csikós J, Cairney CJ, Blitzer A.

Neurology. 2019 Apr 23;92(17):e1982-e1991. doi: 10.1212/WNL.0000000000007368. Epub 2019 Mar 27.

17.

Effectiveness of botulinum neurotoxin type A injections in naïve and previously-treated patients suffering from Torti- or Laterocollis or -caput: Results from a German-Austrian open-label prospective post-marketing surveillance study.

Jost WH, Schramm A, Müngersdorf M, Stenner A, Schwingenschuh P, Maisonobe P, Koch M, Haslinger B.

J Neurol Sci. 2019 Apr 15;399:44-50. doi: 10.1016/j.jns.2019.02.017. Epub 2019 Feb 10.

18.

Dynamics of Parkinson's Disease Multimodal Complex Treatment in Germany from 2010⁻2016: Patient Characteristics, Access to Treatment, and Formation of Regional Centers.

Richter D, Bartig D, Muhlack S, Hartelt E, Scherbaum R, Katsanos AH, Müller T, Jost W, Ebersbach G, Gold R, Krogias C, Tönges L.

Cells. 2019 Feb 11;8(2). pii: E151. doi: 10.3390/cells8020151.

19.

Botulinumtoxin for bladder disorders.

Schulte-Baukloh H, Bauer R, Jost W, Wissel J, van Ophoven A.

Fortschr Neurol Psychiatr. 2019 Feb;87(1):23-30. doi: 10.1055/a-0599-0697. Epub 2018 Dec 3. Review. German.

PMID:
30508871
20.

Bilateral Globus Pallidus Internus Deep Brain Stimulation in a Case of Progressive Dystonia in Mohr-Tranebjaerg Syndrome with Bilateral Cochlear Implants.

Coenen VA, Rijntjes M, Sajonz B, Piroth T, Prokop T, Jost W, Trippel M, Urbach H, Reinacher PC.

J Neurol Surg A Cent Eur Neurosurg. 2019 Jan;80(1):44-48. doi: 10.1055/s-0038-1669472. Epub 2018 Oct 5.

PMID:
30290379

Supplemental Content

Loading ...
Support Center